High materiality9/10
Eli Lilly price target raised to $1,376 from $1,370 at Truist
Why it may matterVerify against the original reporting
Strong upside potential supported by target revision; favorable risk-reward.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raises LLY target to $1,376; current price about $1,177, signaling continued upside.
- Target: 1376
- Posted price: 1177
- Analyst firm: UBS
Key facts
- 01
Target: $1,376
- 02
Posted price: $1,177
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.